Medical reviewer

Fatima Cody Stanford, MD, MPH, MPA, MBA

Obesity medicine physician-scientist at Massachusetts General Hospital and Associate Professor of Medicine and Pediatrics at Harvard Medical School.

Fatima Cody Stanford, MD, MPH, MPA, MBA

Medical reviewer

Obesity medicine physician-scientist at Massachusetts General Hospital. Associate Professor of Medicine and Pediatrics at Harvard Medical School. Among the first fellowship-trained obesity medicine physicians in the world.

Education and training

CredentialInstitution
BS and MPHEmory University (MLK Scholar)
MDMedical College of Georgia School of Medicine
MPAHarvard Kennedy School of Government (Zuckerman Fellow)
Executive MBAQuantic School of Business and Technology
Residency, Internal Medicine / PediatricsPrisma Health-Upstate / University of South Carolina
Fellowship, Obesity Medicine & NutritionMassachusetts General Hospital / Harvard Medical School

Board certifications

American Board of Pediatrics. FAAP, FACP, FAHA, FTOS.

Research areas

Anti-obesity pharmacotherapy (including after bariatric surgery); adolescent bariatric surgery outcomes; BMI as a health measure; weight stigma and bias in healthcare; physician education in obesity care; health disparities.

More than 200 peer-reviewed publications. Co-author on the 2025 Lancet Commission redefining the diagnostic criteria for obesity.

Leadership

  • Chair, Obesity Advisory Committee, American College of Physicians
  • Chair, Minority Affairs Section, American Medical Association
  • Member, Dietary Guidelines for Americans Advisory Committee (2025)
  • Executive Committee, AAP Section on Obesity
  • Board positions with The Obesity Society and the American Heart Association (Massachusetts)

Awards

National Academy of Medicine Scholar in Diagnostic Excellence (2022), The Obesity Society Clinician of the Year (2020), Harvard Medical School Young Mentor Award (2021), AMA Dedication to the Profession Award (2021), Harold Amos Faculty Diversity Award (2017).

Profiles and links

Retatrutide vial
Retatrutide 98%+ purity · third-party tested
$125.00